Andreas Koblet

This inventor holds 14 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 10 EPO patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andreas Koblet. Retrieved from https://idiyas.com/inventor/andreas-koblet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 10)

% Patents Active = 57.1

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 10 (Patent Applications = 11)

Average Co-Inventor Count = 6.5

ph-index = 3

Forward Citations = 24(Granted Patents)

Location History:

Binningen, CH (2011 - 2013)
Bottmingen, CH (2007 - 2016)
Basel, CH (2021 - 2023)
Elsau ZH, CH (2023)

Company Filing History:

14 out of 5,027

Hoffmann-La Roche Inc.

patents

Years Active: 2007-2026

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12747235 - Triazolyl derivatives as GABAα5 PAM (2026-09-29),

2. 12692271 - Substituted benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepines as GABA A GAMMA1 positive allosteric modulators (2026-07-28),

3. 12365687 - Benzodiazepine derivatives as GABA A gamma 1 PAM (2025-07-22),

4. 11840528 - Isoxazolyl ether derivatives as GABAα5 PAM (2023-12-12),

5. 11739095 - Substituted benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepines as GABA A GAMMA1 positive allosteric modulators (2023-08-29),

6. 11091471 - Isoxazolyl ether derivatives as GABAα5 PAM (2021-08-17),

7. 9346786 - Pyrrolidine compounds (2016-05-24),

8. 9226916 - Pyrrolidine derivatives (2016-01-05),

9. 8404708 - Dual NK1/NK3 receptor antagonists (2013-03-26),

10. 8404679 - Pyrrolidine derivatives as NK2 receptor antagonists (2013-03-26),

11. 7956074 - Aryl-isoxazolo-4-yl-oxadiazole derivatives (2011-06-07),

12. 7939533 - Dual NK1/NK3 receptor antagonists (2011-05-10),

13. 7541372 - Aryl-isoxazolo-4-yl-oxadiazole derivatives (2009-06-02),

14. 7211579 - NK-1 receptor antagonists (2007-05-01),

Title: Andreas Koblet - Innovative Inventor from Bottmingen, CH

Introduction: Andreas Koblet is a renowned inventor hailing from Bottmingen, Switzerland, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Andreas Koblet holds several patents in the areas of renewable energy, sustainable agriculture, and advanced materials, showcasing his diverse range of expertise and innovative spirit.

Career Highlights: With a career spanning over two decades, Andreas Koblet has worked with leading research institutions and universities to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Andreas Koblet has collaborated with top companies, innovative startups, and visionary entrepreneurs to bring his inventions to life and make a lasting impact on society.

Conclusion: Andreas Koblet's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology in Switzerland and beyond.

Profile summary based on public USPTO records.